Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group.
about
Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adultsCanadian practice guidelines for surgical intra-abdominal infectionsAddressing Concerns about Changing the Route of Antimicrobial Administration from Intravenous to Oral in Adult InpatientsClinical review: balancing the therapeutic, safety, and economic issues underlying effective antipseudomonal carbapenem useResults of a clinical trial of clinafloxacin versus imipenem/cilastatin for intraabdominal infectionsDescription and validation of a spectrum score method to measure antimicrobial de-escalation in healthcare associated pneumonia from electronic medical records data.Treatment of the intraabdominal abscesses through percutaneous ultrasound-guided drainage in oncological patients: Clinical and microbiological data.New advances in the use of antimicrobial agents in surgery: intra-abdominal infections.Use of antibiotics in uncomplicated diverticulitis.Intravenous to oral (iv:po) anti-infective conversion therapy.Complicated intra-abdominal infections: a focus on appendicitis and diverticulitis.Antimicrobial effect of intracanal substances.Combination therapy for treatment of infections with gram-negative bacteria.Prevention of infectious complications in severe acute pancreatitis with systemic antibiotics: where are we now?Management of peritonitis in the critically ill patientTigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infections.Intra-abdominal infections: considerations for the use of the carbapenems.Management of severe sepsis of abdominal origin.Carbapenems: a potent class of antibiotics.Outcomes of early switching from intravenous to oral antibiotics on medical wards.Parenteral to oral conversion of fluoroquinolones: low-hanging fruit for antimicrobial stewardship programs?Source control review in clinical trials of anti-infective agents in complicated intra-abdominal infections.Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): clinical and economic outcomes of averted cases.Optimal Treatment for Complicated Intra-abdominal Infections in the Era of Antibiotic Resistance: A Systematic Review and Meta-Analysis of the Efficacy and Safety of Combined Therapy With MetronidazoleAntimicrobial Monotherapy versus Combination Therapy for the Treatment of Complicated Intra-Abdominal Infections.Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections.Sequential intravenous/oral antibiotic vs. continuous intravenous antibiotic in the treatment of pyogenic liver abscess.Postoperative enterococcal infection after treatment of complicated intra-abdominal sepsis.Comparative in-vitro activities of ertapenem against aerobic bacterial pathogens isolated from patients with complicated intra-abdominal infections.
P2860
Q24246927-277F9812-EF05-4CEC-BC6B-2C2DB69B679DQ24599288-7EE358A7-BC31-465F-9129-7D8CEC2F0762Q26795605-DD285E37-64EE-451D-B726-65935202791CQ28299749-FBBE501A-AA52-4800-AA5A-ACD8D65A0784Q28345630-57E3597E-1D53-4933-A9E3-D81D5C744C55Q30647100-54C34CF4-C723-4A3D-A2E4-E7D8A1F7ED56Q33303029-6D631EB0-4510-4DEF-B0A1-233FC1D75686Q33840063-9A1E2708-D958-467B-ACA6-77CBBF07C104Q33882720-FF2CC2AA-CDCA-407F-BC8F-E2EE151FF7CFQ33900408-948FCBA1-9761-43E3-854B-8DEABF05F35EQ34095187-06D70864-1AEA-406F-8B97-67F049CDBD99Q35081375-3FFDB6A6-9E87-429F-B2F4-B82FFC46C7D7Q36156077-1EF1B4CE-7AD3-4DED-B03A-16027E480EF9Q36162369-B0BC696D-E43F-4E41-9D19-EEEE87BD8F73Q36658471-F2912FD9-F54E-42ED-B82E-23E9603EC8E9Q36663656-3DDD19B1-320A-4BCD-A234-C6379B113376Q36719679-B3A24C04-2F7B-42BB-8320-6DBCDD8368EDQ36984156-ACBA5DF1-A09F-490F-B4BA-F1BDC15C7807Q37030838-A0336512-BB91-43F8-84C5-848EDCAAC732Q37217090-54C4177F-48C6-46CE-BA5A-6D91048B6E3AQ37993715-3047B686-C2CF-4E16-A061-253A23E7661FQ38086810-EE943F66-B40D-4673-92AC-0F7B1D6FF8DDQ38188534-7B9DAB23-38A7-4497-BF06-B890FA798742Q38972381-26B21DA6-9516-47A5-B7AF-4CF9F67C8B94Q40511035-CF710BA0-6AF4-4AAB-BC7D-7383915EDA52Q40558538-62EC4622-C81A-4DBF-B13B-6EBF6B1951AEQ43431507-C03A2F8C-4B33-49E4-B3AF-9FB64005686DQ43901109-00918C45-E989-4CD6-89C3-8CD965CA4F4DQ44066002-C23DF4FF-AE67-4291-A55B-355318A6E1FF
P2860
Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Results of a randomized trial ...... dominal Infection Study Group.
@en
Results of a randomized trial ...... dominal Infection Study Group.
@nl
type
label
Results of a randomized trial ...... dominal Infection Study Group.
@en
Results of a randomized trial ...... dominal Infection Study Group.
@nl
prefLabel
Results of a randomized trial ...... dominal Infection Study Group.
@en
Results of a randomized trial ...... dominal Infection Study Group.
@nl
P2093
P1433
P1476
Results of a randomized trial ...... dominal Infection Study Group.
@en
P2093
Bjornson HS
Coulter HO
Dellinger EP
Haverstock DC
Reinhart HH
Rotstein OD
P304
P356
10.1097/00000658-199603000-00012
P407
P577
1996-03-01T00:00:00Z